United States· US:0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931
Xiidra
A lifitegrast product containing lifitegrast, registered in United States by Novartis Pharmaceuticals Corporation. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lifitegrast is registered in 4 of 19 countries.
Countries holding a registration under ATC S01XA25 (lifitegrast), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Lifitegrast · ATC S01XA25
4 / 19 countries
- Canada
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LIFITEGRAST
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- S01XA25
- ATC class
- Lifitegrast
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11007809111212 POUCH in 1 CARTON (0078-0911-12) / 5 AMPULE in 1 POUCH (0078-0911-05) / .2 mL in 1 AMPULE
- ndc1100780911944 POUCH in 1 CARTON (0078-0911-94) / 5 AMPULE in 1 POUCH (0078-0911-95) / .2 mL in 1 AMPULE
- ndc110078-0911-12
- ndc110078-0911-94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lifitegrast in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75dfe2f5-487f-4cae-9cc7-1be70bf50144 GET /v1/drugs/75dfe2f5-487f-4cae-9cc7-1be70bf50144?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "50",
"substance": "LIFITEGRAST",
"productndc": "0078-0911",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA208073",
"marketing_category": "NDA"
}See everything about lifitegrast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.